Abstract

Crosstalk between the SUMO and ubiquitin pathways has recently been reported. However, no approach currently exists to determine the interrelationship between these modifications. Here, we report an optimized immunoaffinity method that permits the study of both protein ubiquitylation and SUMOylation from a single sample. This method enables the unprecedented identification of 10,388 SUMO sites in HEK293 cells. The sequential use of SUMO and ubiquitin remnant immunoaffinity purification facilitates the dynamic profiling of SUMOylated and ubiquitylated proteins in HEK293 cells treated with the proteasome inhibitor MG132. Quantitative proteomic analyses reveals crosstalk between substrates that control protein degradation, and highlights co-regulation of SUMOylation and ubiquitylation levels on deubiquitinase enzymes and the SUMOylation of proteasome subunits. The SUMOylation of the proteasome affects its recruitment to promyelocytic leukemia protein (PML) nuclear bodies, and PML lacking the SUMO interacting motif fails to colocalize with SUMOylated proteasome further demonstrating that this motif is required for PML catabolism.

Highlights

  • Crosstalk between the small ubiquitin related modifier (SUMO) and ubiquitin pathways has recently been reported

  • The optimized SUMOylated peptide immunopurification protocol provides an efficient approach to obtain unambiguous identification of SUMOylation sites on protein substrates. This approach enabled the proteome-wide identification of 10,388 SUMO sites on 3,556 proteins in HEK293 cells

  • Half of these sites were identified in recent large-scale SUMO proteome analyses that used different cell lines and stimuli

Read more

Summary

Introduction

Crosstalk between the SUMO and ubiquitin pathways has recently been reported. no approach currently exists to determine the interrelationship between these modifications. The combination of lysine labelling with the overexpression of a wild-type (WT) like mutant has been reported[21] While these approaches have been designed to enrich SUMOylated peptides from complex cell extracts, they cannot be used alone to uncover the prevalence and significance of crosstalk between UBL modifiers. We developed a combined immunoaffinity enrichment strategy that enables the identification of UBL-modified proteins and applied this method to examine crosstalk between SUMOylation and ubiquitylation in the context of protein degradation Using this approach, we found several interplay between SUMO and ubiquitin including the co-regulation of SUMOylation and Ubiquitylation levels on deubiquitinase enzymes and the SUMOylation of the proteasome for its recruitment to promyelocytic leukemia protein (PML) nuclear bodies (NBs)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.